New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
Authors
Keywords
-
Journal
JOURNAL OF NEUROSCIENCE RESEARCH
Volume 94, Issue 11, Pages 1203-1219
Publisher
Wiley
Online
2016-09-17
DOI
10.1002/jnr.23762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity
- (2016) D. Shin et al. JOURNAL OF NEUROSCIENCE
- Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants
- (2016) Samantha J. Spratley et al. TRAFFIC
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- TALEN-mediated genome engineering to generate targeted mice
- (2015) Daniel Sommer et al. CHROMOSOME RESEARCH
- Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations
- (2015) Mohammad Arif Hossain et al. JOURNAL OF HUMAN GENETICS
- Lysosomal storage disease: Gene therapy on both sides of the blood–brain barrier
- (2015) Elena L. Aronovich et al. MOLECULAR GENETICS AND METABOLISM
- CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
- (2015) Zhuchi Tu et al. Molecular Neurodegeneration
- Enzyme Enhancers for the Treatment of Fabry and Pompe Disease
- (2015) Jan Lukas et al. MOLECULAR THERAPY
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- Azasugar inhibitors as pharmacological chaperones for Krabbe disease
- (2015) Chris H. Hill et al. Chemical Science
- Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease
- (2014) Daniela Zizioli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Iminosugar-Based Galactoside Mimics as Inhibitors of Galactocerebrosidase: SAR Studies and Comparison with Other Lysosomal Galactosidases
- (2014) Anna Biela-Banaś et al. ChemMedChem
- The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases
- (2014) James A. Shayman et al. JOURNAL OF LIPID RESEARCH
- Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients
- (2014) Anna Sara Berardi et al. MOLECULAR GENETICS AND METABOLISM
- A Hitchhiker's Guide to the Blood–brain Barrier: In Trans Delivery of a Therapeutic Enzyme
- (2014) Mark S Sands MOLECULAR THERAPY
- Sphingolipid lysosomal storage disorders
- (2014) Frances M. Platt NATURE
- Generating genetically modified mice using CRISPR/Cas-mediated genome engineering
- (2014) Hui Yang et al. Nature Protocols
- Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system
- (2014) Masafumi Inui et al. Scientific Reports
- Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease
- (2013) Yoshiyuki Suzuki BRAIN & DEVELOPMENT
- Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: Implication for Krabbe disease
- (2013) Je-Seong Won et al. BRAIN RESEARCH
- Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease
- (2013) Gregory B. Potter et al. HUMAN MOLECULAR GENETICS
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 2 study of migalastat hydrochloride in females with Fabry disease: Selection of population, safety and pharmacodynamic effects
- (2013) R. Giugliani et al. MOLECULAR GENETICS AND METABOLISM
- Krabbe disease: Are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?
- (2013) David A. Wenger et al. MOLECULAR GENETICS AND METABOLISM
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- (2013) Woong Y Hwang et al. NATURE BIOTECHNOLOGY
- Structural snapshots illustrate the catalytic cycle of -galactocerebrosidase, the defective enzyme in Krabbe disease
- (2013) C. H. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A high-throughput screening assay using Krabbe disease patient cells
- (2012) Jameson Ribbens et al. ANALYTICAL BIOCHEMISTRY
- Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
- (2012) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Reverse Genetic Approaches in Zebrafish
- (2012) Peng Huang et al. Journal of Genetics and Genomics
- Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy
- (2012) Elizabeth Y. Qin et al. MOLECULAR GENETICS AND METABOLISM
- Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease
- (2012) Mohammad A Rafi et al. MOLECULAR THERAPY
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine
- (2012) Caterina Porto et al. MOLECULAR THERAPY
- Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
- (2012) Dominique P Germain et al. Orphanet Journal of Rare Diseases
- Pharmacological chaperone therapy for Fabry disease
- (2012) Satoshi ISHII PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase
- (2011) Abigail I. Guce et al. CHEMISTRY & BIOLOGY
- Endosome maturation
- (2011) Jatta Huotari et al. EMBO JOURNAL
- Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?
- (2011) J. A. Hawkins-Salsbury et al. HUMAN MOLECULAR GENETICS
- Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
- (2011) Anna Kloska et al. METABOLIC BRAIN DISEASE
- Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase
- (2011) Olga Abian et al. MOLECULAR PHARMACEUTICS
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Insights into Krabbe disease from structures of galactocerebrosidase
- (2011) J. E. Deane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Iminosugars past, present and future: medicines for tomorrow
- (2010) Graeme Horne et al. DRUG DISCOVERY TODAY
- Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease
- (2010) Barbara Tappino et al. HUMAN MUTATION
- 7,3′,4′-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase
- (2010) Dong Eun Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones
- (2010) Audrey Arfi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
- (2010) W. C. Lee et al. JOURNAL OF NEUROSCIENCE
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Targeted integration in rat and mouse embryos with zinc-finger nucleases
- (2010) Xiaoxia Cui et al. NATURE BIOTECHNOLOGY
- Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis
- (2010) Derrick Sek Tong Ong et al. Nature Chemical Biology
- High content screening: seeing is believing
- (2010) Fabian Zanella et al. TRENDS IN BIOTECHNOLOGY
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability
- (2009) Raquel L. Lieberman et al. BIOCHEMISTRY
- Specific Determination of -Galactocerebrosidase Activity via Competitive Inhibition of -Galactosidase
- (2009) S. Martino et al. CLINICAL CHEMISTRY
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Psychosine Accumulates in Membrane Microdomains in the Brain of Krabbe Patients, Disrupting the Raft Architecture
- (2009) A. B. White et al. JOURNAL OF NEUROSCIENCE
- Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells
- (2009) Brigitte Rigat et al. MOLECULAR GENETICS AND METABOLISM
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
- (2009) Reinhard Gabathuler NEUROBIOLOGY OF DISEASE
- Newborn Screening for Krabbe Disease: the New York State Model
- (2009) Patricia K. Duffner et al. PEDIATRIC NEUROLOGY
- A Model in Response to Newborn Screening Mandates
- (2009) Patricia K. Duffner PEDIATRIC NEUROLOGY
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
- (2008) Jin-Song Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lysosomal disorders: From storage to cellular damage
- (2008) Andrea Ballabio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- ortho-Dihydroxyisoflavone derivatives from aged Doenjang (Korean fermented soypaste) and its radical scavenging activity
- (2008) Jun-Seong Park et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-α-l-iduronidase Fusion Gene Product
- (2008) Mark J Osborn et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Therapeutic approaches in glycogen storage disease type II/pompe disease
- (2008) Benedikt Schoser et al. Neurotherapeutics
- Chemically modified -glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII
- (2008) J. H. Grubb et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis
- (2008) Ting-Wei Mu et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now